{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:15:38Z","timestamp":1649070938482},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ygyno.2012.10.012","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T23:18:17Z","timestamp":1352243897000},"page":"437-439","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing cervical cancer prevention strategies in the United States"],"prefix":"10.1016","volume":"127","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Schmeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.10.012_bb0005","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0010","article-title":"A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination","volume":"10","author":"Wheeler","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-148-7-200804010-00004","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"Datta","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1055-9965.EPI-05-0577","article-title":"Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0035","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0040","doi-asserted-by":"crossref","first-page":"b2569","DOI":"10.1136\/bmj.b2569","article-title":"Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study","volume":"339","author":"Castle","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","author":"Kjaer","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/aje\/kwn036","article-title":"Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis","volume":"168","author":"Koshiol","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0060","first-page":"5","article-title":"Cervical cancer inquiry","volume":"16","year":"1988","journal-title":"N Z Nurs Forum"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMp020178","article-title":"Adding a test for human papillomavirus DNA to cervical-cancer screening","volume":"348","author":"Wright","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0075","first-page":"915","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0080","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1086\/428779","article-title":"A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica","volume":"191","author":"Castle","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0085","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-12-2635","article-title":"Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women","author":"Rositch","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0090","doi-asserted-by":"crossref","first-page":"b3884","DOI":"10.1136\/bmj.b3884","article-title":"Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States","volume":"339","author":"Kim","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0095","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0100","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S1470-2045(12)70328-5","article-title":"Australia to be first country to vaccinate boys against HPV","volume":"13","author":"Kirby","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0105","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"97","key":"10.1016\/j.ygyno.2012.10.012_bb0115","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"20","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0125","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0130","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JCM.01315-10","article-title":"Feasibility study of a human papillomavirus e6 oncoprotein test for diagnosis of cervical precancer and cancer","volume":"48","author":"Schweizer","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2012.10.012_bb0135","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1128\/CVI.00388-12","article-title":"Direct human papillomavirus e6 whole-cell enzyme-linked immunosorbent assay for objective measurement of e6 oncoproteins in cytology samples","volume":"19","author":"Yang","year":"2012","journal-title":"Clin Vaccine Immunol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812008141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812008141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T17:24:46Z","timestamp":1540142686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812008141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0090825812008141"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.10.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}